Plasmacytoid Urothelial Carcinoma of the Bladder That Manifests Disseminated Carcinomatosis of the Bone Marrow: A Case Report of Extremely Rapid Progression-Reference-Cited by-同舟云学术

Plasmacytoid Urothelial Carcinoma of the Bladder That Manifests Disseminated Carcinomatosis of the Bone Marrow: A Case Report of Extremely Rapid Progression

Published:2022-09-15 Issue: Volume:2022 Page:1-5
ISSN:2090-6978
Container-title:Case Reports in Urology
language:en
Short-container-title:Case Reports in Urology

Author:

Shimizu Nobuhiko¹,Moritoki Yoshinobu¹²^ORCID,Katsumi Nao¹,Yanase Takahiro³,Sugino Teruaki³,Kanemoto Kazuhiro¹,Akita Hidetoshi¹,Yasui Takahiro³

Affiliation:

1. Department of Urology, Anjo Kosei Hospital, Anjo, Japan

2. Department of Urology, Toyokawa City Hospital, Toyokawa, Japan

3. Department of Nephro-Urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

Abstract

Plasmacytoid urothelial carcinoma (PUC) of the bladder is a rare variant of invasive urothelial carcinoma (UC) with aggressive behavior. Despite its prognosis being poorer than that of conventional UC, a median overall survival of approximately 2 years is ensured when it is treated with radical cystectomy (RC), and few patients die within a few months of RC. In this paper, we report the case of a patient with PUC who developed widespread bone metastasis only 6 weeks after RC, which resulted in death within 2 months postoperatively.

Publisher

Hindawi Limited

Subject

General Medicine

Link

http://downloads.hindawi.com/journals/criu/2022/6082700.pdf

Reference11 articles.

1. Plasmacytoid Variant Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-Analysis of Clinicopathological Features and Survival Outcomes

2. Plasmacytoid Urothelial Carcinoma: An Unusual Variant That Warrants Aggressive Management and Critical Distinction on Transurethral Resections

3. Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy

4. Histological Variants of Urothelial Carcinoma Predict No Response to Neoadjuvant Chemotherapy

5. What Is the Prognostic and Clinical Importance of Urothelial and Nonurothelial Histological Variants of Bladder Cancer in Predicting Oncological Outcomes in Patients with Muscle-invasive and Metastatic Bladder Cancer? A European Association of Urology Muscle Invasive and Metastatic Bladder Cancer Guidelines Panel Systematic Review

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differentiation Between Disseminated Carcinomatosis of the Bone Marrow From Urothelial Cancer and Intravascular Large B-cell Lymphoma: A Case Report;Cureus;2024-03-29